» Articles » PMID: 19687056

Real-time Reverse Linkage Using Polar Body Analysis for Preimplantation Genetic Diagnosis in Female Carriers of De Novo Mutations

Overview
Journal Hum Reprod
Date 2009 Aug 19
PMID 19687056
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Single cell diagnosis for preimplantation genetic diagnosis (PGD) requires simultaneous analysis of multiple linked polymorphic markers in addition to mutation analysis in order to reduce misdiagnosis. This type of analysis requires building family haplotypes spanning at least two generations. We present three childless couples in whom the female was a de novo mutation carrier in the Duchenne Muscular Dystrophy (DMD), incontinentia pigmenti (IKBKG) or Neurofibromatosis type 2 (NF2) genes, precluding linkage prior to the PGD cycle. We constructed haplotypes based on linked polymorphic markers in these families and performed concurrent diagnosis enabling embryo transfer from the first PGD cycle.

Methods: Informative markers flanking the DMD, IKBKG and NF2 genes were used to construct non-linked haplotypes. Polar bodies 1 (PB1) and 2 (PB2) were biopsied and analyzed to determine allelic association between the mutation and markers in multiplex PCR reactions.

Results: For each family, the first PGD cycle allowed the establishment of linked haplotypes based on homozygous PB1 and PB2 analysis; however, no embryos were available for transfer. Subsequent cycles, when performed, confirmed this linkage. A mutation-free child was born to the family affected with DMD and an ongoing pregnancy (32 weeks) was achieved with the carrier of the IKBKG deletion.

Conclusions: PB analysis for reverse linkage in real-time coupled with the PGD cycle is a powerful tool for diagnosis and linkage between markers and de novo mutations for maternal autosomal dominant or X-linked disorders. Simultaneous amplification of multiple informative markers in conjunction with the mutation allows the building of familial haplotypes and accurate PGD analysis.

Citing Articles

The clinical application of affected-embryo-based SNP haplotype analysis for patients with de novo pathogenic mutations in PGT-M cycles.

Wang J, Xing J, Chen L, Diao Z, He L, Wang S Arch Gynecol Obstet. 2024; 310(6):3195-3208.

PMID: 39470770 DOI: 10.1007/s00404-024-07773-y.


Preimplantation genetic testing for embryos predisposed to hereditary cancer: Possibilities and challenges.

Albujja M, Al-Ghedan M, Dakshnamoorthy L, Pla Victori J Cancer Pathog Ther. 2024; 2(1):1-14.

PMID: 38328708 PMC: 10846329. DOI: 10.1016/j.cpt.2023.05.002.


A whole-genome sequencing-based novel preimplantation genetic testing method for de novo mutations combined with chromosomal balanced translocations.

Yuan P, Xia J, Ou S, Liu P, Du T, Zheng L J Assist Reprod Genet. 2020; 37(10):2525-2533.

PMID: 32783137 PMC: 7550397. DOI: 10.1007/s10815-020-01921-4.


A healthy delivery of twins by assisted reproduction followed by preimplantation genetic screening in a woman with X-linked dominant incontinentia pigmenti.

Kim M, Lyu S, Seok H, Park J, Shim S, Yoon T Clin Exp Reprod Med. 2015; 41(4):168-73.

PMID: 25599040 PMC: 4295944. DOI: 10.5653/cerm.2014.41.4.168.


Evaluation of PCR-based preimplantation genetic diagnosis applied to monogenic diseases: a collaborative ESHRE PGD consortium study.

Dreesen J, Destouni A, Kourlaba G, Degn B, Mette W, Carvalho F Eur J Hum Genet. 2013; 22(8):1012-8.

PMID: 24301057 PMC: 4350594. DOI: 10.1038/ejhg.2013.277.